Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registry

To determine the safety and efficacy of anifrolumab in patients with systemic lupus erythematosus (SLE) classified based on the Lupus Low Disease Activity State (LLDAS) in real-world clinical practice. This retrospective observational study involved SLE patients who started anifrolumab therapy. The...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Rheumatology (Oxford, England) England), 2024-09, Vol.63 (9), p.2345-2354
Hauptverfasser:	Miyazaki, Yusuke, Funada, Masashi, Nakayamada, Shingo, Sonomoto, Koshiro, Tanaka, Hiroaki, Hanami, Kentaro, Fukuyo, Shunsuke, Kubo, Satoshi, Yamaguchi, Ayako, Miyagawa, Ippei, Todoroki, Yasuyuki, Ueno, Masanobu, Tanaka, Yoshiya
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Female Glucocorticoids - therapeutic use Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Lupus Erythematosus, Systemic - drug therapy Male Middle Aged Registries Retrospective Studies Severity of Illness Index Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!